Placental passage of metformin in women with polycystic ovary syndrome
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 83 (5), 1575-1578
- https://doi.org/10.1016/j.fertnstert.2004.11.051
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized studyHuman Reproduction, 2004
- Rapid determination of metformin in human plasma by liquid chromatography−tandem mass spectrometry methodJournal of Chromatography B, 2004
- Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancyHuman Reproduction, 2004
- Metformin in polycystic ovary syndrome: systematic review and meta-analysisBMJ, 2003
- Pregnancy outcomes among women with polycystic ovary syndrome treated with metforminHuman Reproduction, 2002
- Ovarian Function and Metabolic Factors in Women with Oligomenorrhea Treated with Metformin in a Randomized Double Blind Placebo-Controlled TrialJournal of Clinical Endocrinology & Metabolism, 2002
- Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metforminAmerican Journal of Obstetrics and Gynecology, 1997
- Metformin kinetics in healthy subjects and in patients with diabetes mellitus.British Journal of Clinical Pharmacology, 1981
- Metformin in management of pregnant insulin-independent diabeticsDiabetologia, 1979
- Pharmacokinetics of metformin after intravenous and oral administration to manEuropean Journal of Clinical Pharmacology, 1979